Lineage Cell Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Lineage Cell Therapeutics, Inc. (LCTX) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2017-03-16
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2016-12-31 was $0.00.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2015-12-31 was $0.00.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2014-12-31 was $0.00.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2015 was $100.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- Lineage Cell Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2013 was $15.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 10-K · filed 2017-03-16 | ||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-04 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $100.00K 10-K · filed 2017-03-16 | ||
| 2015-09-30 | $100.00K 10-Q · filed 2016-11-04 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 10-K · filed 2017-03-16 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $10.00K derived: sum of 2 quarters · filed 2016-03-15 | $15.00K 10-K · filed 2016-03-15 | |
| 2013-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $15.00K 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | $5.00K 10-Q · filed 2014-08-11 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $0.00 derived: sum of 2 quarters · filed 2015-03-11 | $0.00 10-K · filed 2015-03-11 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |